LC216 calculator
A supplier-branded research compound. There is no meaningful published evidence base for it.
Also known as: LC216 peptide
FDA status — not an approved drug Not FDA-approved for any use. LC216 is a research compound with no established evidence base and is not reviewed by FDA.
Schedule LC216 → Set your dosing schedule and get a phone notification when each dose is due. Free.
What LC216 is
LC216 is a name used by research suppliers for a compound without a meaningful presence in the peer-reviewed scientific literature. There is no reliable evidence to describe what it does, whether it works, or whether it is safe.
Research depth: 1/5 No meaningful published research exists for this compound. Human trials: None. This measures how much has been studied — counting animal and laboratory work — not whether it works for you.
How LC216 works
No established mechanism can be described because there is no published research characterizing this compound's pharmacology. Any mechanism claimed by suppliers is unverified.
LC216 side effects
Commonly reported
- No human safety data
- Effects are uncharacterized
Serious — seek medical care
- No published research to establish safety or efficacy
- Composition and identity vary by supplier
- Unregulated products carry contamination and purity risks
This list is not exhaustive. Report anything unexpected to the clinician who prescribed it. If you have severe abdominal pain, trouble breathing, or signs of an allergic reaction, seek care the same day. See also our guide to peptide side effects by class.
A worked example
A 10 mg vial reconstituted with 2 mL of bacteriostatic water gives 5 mg/mL. A 1000 mcg dose is then 0.2 mL — about 20 units on a 100-unit insulin syringe, giving roughly 10 doses per vial before accounting for residual volume left in the vial and syringe.
Prefer paper? Download the printable LC216 dosing chart (PDF) — every vial size and water volume in syringe units, with the same review byline as this page. All charts →
Commonly cited dose range
Figures circulating for LC216 run from 500 mcg to 2000 mcg. No established dosing exists — there is essentially no published research on this compound. Figures shown are supplier reference points in micrograms.
Read this as reference information, not instruction. These numbers describe what is commonly discussed, not what is right for any individual. Dose, frequency, and whether to use LC216 at all are decisions for a licensed clinician who knows your history.
Common questions
Is there research on LC216?
Effectively none in the peer-reviewed literature. It is a supplier-branded research compound without published clinical or preclinical studies to evaluate.
Is LC216 approved?
No. It is an unregulated research compound with no approved use and no evidence base.